| Pergoveris (450 IU + 225 IU)/0.72 mL solution for injection in pre-filled pen EU/1/07/396/005 |
Lutropin alfa, Follitropin alfa |
Merck Europe B.V. |
— |
| Pergoveris (900 IU + 450 IU)/1.44 mL solution for injection in pre-filled pen EU/1/07/396/006 |
Lutropin alfa, Follitropin alfa |
Merck Europe B.V. |
— |
| Pergoveris 150 IU/75 IU powder and solvent for solution for injection EU/1/07/396/1-3 |
Lutropin alfa, Follitropin alfa |
Merck Europe B.V. |
— |
| Perjeta 420 mg concentrate for solution for infusion EU/1/13/813/001 |
Pertuzumab |
Roche Registration GmbH |
— |
| Pethidine Hydrochloride 50mg/ml Solution for Injection PA0073/014/001 |
Pethidine hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Peyona 20 mg/mL solution for infusion and oral solution EU/1/09/528/001 |
Caffeine citrate |
Chiesi Farmaceutici S.p.A. |
— |
| PHEBURANE 350 mg/mL oral solution EU/1/13/822/006 |
Sodium phenylbutyrate |
Eurocept International BV |
— |
| PHEBURANE 483 mg/g granules EU/1/13/822/001 |
Sodium 4-phenylbutyrate |
Eurocept International BV |
— |
| PHELINUN 200 mg powder and solvent for concentrate for solution for infusion EU/1/20/1487/002 |
MELPHALAN HYDROCHOLORIDE |
Adienne S.r.l. S.U. |
— |
| PHELINUN 50 mg powder and solvent for concentrate for solution for infusion EU/1/20/1487/001 |
MELPHALAN HYDROCHOLORIDE |
Adienne S.r.l. S.U. |
— |
| Phenylephrine Hydrochloride 10 mg/ml solution for injection/infusion PA1418/011/001 |
Phenylephrine hydrochloride |
Athlone Pharmaceuticals Limited |
Marketed |
| Phesgo 1200 mg/600 mg solution for injection EU/1/20/1497/001 |
Pertuzumab, Trastuzumab |
Roche Registration GmbH |
— |
| Phesgo 600 mg/600 mg solution for injection EU/1/20/1497/002 |
Pertuzumab, Trastuzumab |
Roche Registration GmbH |
— |
| PHYLLOCONTIN 225 mg Prolonged Release Tablets PA23369/001/001 |
Aminophylline hydrate |
Ennogen Healthcare (Europe) Limited |
Not marketed |
| Piasky EU/1/24/1848/001 |
Crovalimab |
Roche Registration GmbH |
— |
| Pifeltro 100 mg film-coated tablets EU/1/18/1332/001-002 |
Doravirine |
Merck Sharp & Dohme BV, |
— |
| Pioglitazone Accord 15 mg tablets EU/1/11/722/001-010 |
Pioglitazone hydrochloride |
Accord Healthcare S.L.U. |
— |
| Pioglitazone Accord 30 mg tablets EU/1/11/722/011-020 |
Pioglitazone hydrochloride |
Accord Healthcare S.L.U. |
— |
| Pioglitazone Accord 45 mg tablets EU/1/11/722/021-030 |
Pioglitazone hydrochloride |
Accord Healthcare S.L.U. |
— |
| Pioglitazone Actavis 15 mg tablets EU/1/12/755/001-009 |
Pioglitazone hydrochloride |
Actavis Group hf |
— |
| Pioglitazone Actavis 30 mg tablets EU/1/12/755/010-018 |
Pioglitazone hydrochloride |
Actavis Group hf |
— |
| Pioglitazone Actavis 45 mg tablets EU/1/12/755/019-027 |
Pioglitazone hydrochloride |
Actavis Group hf |
— |
| Piperacillin/Tazobactam 2 g/0.25 g powder for solution for infusion PA2059/016/001 |
Piperacillin, Tazobactam |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Piperacillin/Tazobactam 4 g/0.5 g powder for solution for infusion PA2059/016/002 |
Piperacillin, Tazobactam |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Piperacillin/Tazobactam Aurobindo 2 g/0.25 g powder for solution for infusion PA23467/001/001 |
Piperacillin, Tazobactam |
Eugia Pharma (Malta) Limited |
Not marketed |
| Piperacillin/Tazobactam Aurobindo 4 g/0.5 g powder for solution for infusion PA23467/001/002 |
Piperacillin, Tazobactam |
Eugia Pharma (Malta) Limited |
Marketed |
| Piqray 150 mg film-coated tablets EU/1/20/1455/001-003 |
Alpelisib |
Novartis Europharm Limited |
— |
| Piqray 200 mg film-coated tablets EU/1/20/1455/007-009 |
Alpelisib |
Novartis Europharm Limited |
— |
| Piqray 50 mg film-coated tablets Piqray 200 mg film-coated tablets EU/1/20/1455/004-006 |
Alpelisib |
Novartis Europharm Limited |
— |
| Pirfenidone axunio 267 mg film-coated tablets EU/1/22/1655/001-004 |
Pirfenidone |
Axunio Pharma GmbH |
— |
| Pirfenidone axunio 534 mg film-coated tablets EU/1/22/1655/005-006 |
Pirfenidone |
Axunio Pharma GmbH |
— |
| Pirfenidone Axunio 801 film-coated tablets EU/1/22/1655/007-010 |
Pirfenidone |
Axunio Pharma GmbH |
— |
| Pirfenidone Cipla 267 mg Film-coated Tablets PA1963/016/001 |
Pirfenidone |
Cipla Europe |
Not marketed |
| Pirfenidone Cipla 801 mg Film-coated Tablets PA1963/016/002 |
Pirfenidone |
Cipla Europe |
Not marketed |
| Pirfenidone MSN 267 mg film-coated tablets PA23250/023/001 |
Pirfenidone |
MSN Labs Europe Limited |
Not marketed |
| Pirfenidone MSN 801 mg film-coated tablets PA23250/023/002 |
Pirfenidone |
MSN Labs Europe Limited |
Not marketed |
| Pirfenidone Viatris 267 mg film-coated tablets EU/1/22/1707/001-007 |
Pirfenidone |
Viatris Limited |
— |
| Pirfenidone Viatris 534 mg film-coated tablets EU/1/22/1707/008-010 |
Pirfenidone |
Viatris Limited |
— |
| Pirfenidone Viatris 801 mg film-coated tablets EU/1/22/1707/011-015 |
Pirfenidone |
Viatris Limited |
— |
| Plavix 300 mg film-coated tablets EU/1/98/069/008-010 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Plavix 75 mg film-coated tablets EU/1/98/069/001-007 |
Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Plegridy EU/1/14/934/002 |
Peginterferon beta-1a |
Biogen Netherlands B.V. |
— |
| Plegridy 125 micrograms solution for injection in pre-filled pen EU/1/14/934/005-006 |
Peginterferon beta-1a |
Biogen Netherlands B.V. |
— |
| Plegridy 125 micrograms solution for injection in pre-filled syringe EU/1/14/934/003-004 |
Peginterferon beta-1a |
Biogen Netherlands B.V. |
— |
| Plegridy 63 micrograms solution for injection in pre-filled syringe EU/1/14/934/001-002 |
Peginterferon beta-1a |
Biogen Netherlands B.V. |
— |
| Plenadren 20 mg modified-release tablets EU/1/11/715/002 |
Hydrocortisone |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Plenadren 5 mg modified-release tablets EU/1/11/715/001 |
Hydrocortisone |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| Plerixafor 20 mg/ml solution for injection PA23250/001/001 |
Plerixafor |
MSN Labs Europe Limited |
Marketed |
| Plerixafor Accord 20 mg/ml solution for injection EU/1/22/1701/001 |
Plerixafor |
Accord Healthcare S.L.U. |
— |
| Plerixafor Seacross 20 mg/ml solution for injection PA22766/007/001 |
Plerixafor |
Seacross Pharma (Europe) Limited |
Marketed |